Actelion Pharmaceuticals Ltd is a biopharmaceutical company headquartered in Allschwil/Basel, Switzerland, focusing on the discovery, development and commercialization of innovative treatments to serve high unmet medical needs.

Actelion presents its strategy for value creation

Jean-Paul Clozel, CEO “I am committed to value creation
for our shareholders. After the promising macitentan
results, Actelion will more than ever continue its effort
in the PAH market."

Jean-Paul Clozel, CEO “I am committed to value creation
for our shareholders. After the promising macitentan
results, Actelion will more than ever continue its effort
in the PAH market."